Molecular signature associated with cladribine treatment in patients with multiple sclerosis

Molecular signature associated with cladribine treatment in patients with multiple sclerosis

IntroductionLittle is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood cells, and second to identify potential treatment...

Full description

Bibliographic Details
Main Authors: Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borràs, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
multiple sclerosis
cladribine
biomarkers
omics
bioinformatics
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1233546/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1233546/full

Similar Items